🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Followers are urged to message these accounts directly for source information, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a flourishing trade exists on Telegram, where communities with thousands of participants share comparison images, administration instructions and claims of next-day UK delivery. Vendors market the drug there before redirecting buyers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Professionals Voice Concerns

Nevertheless, physicians and pharmacists have warned that the sale of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to users injecting substances of uncertain source.

Some professionals stated the demand for the experimental drug could be linked to the increasing price of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and supply can still violate medicines, marketing, and consumer laws, risking penalties, legal action or prison.

Platform Reaction and Material Elimination

According to the social media company, the service has removed violative material and banned associated hashtags and query recommendations. The organization said it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.

Online Marketplace Operations

Research also discovered groups with up to 9,000 members marketing retatrutide using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of members, populated with images of slimming results, positive testimonials and detailed guides for mixing or injecting at home.

Within minutes of entering one community, a seller shared WhatsApp details, where most transactions take place. The seller provided an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about weight, health issues or previous experience.

Item Details and Pricing

Inside these groups, posts display black plastic packages with Royal Mail stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with purified liquid, or ready-to-use injectors typically priced at £160 for 20mg. When asked how long a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service stated it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are injecting substances they can’t verify. Although the science behind this drug is sound, these online versions may not include what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are using online platforms. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has previously seen patients injured by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational product not yet approved … may expose users to possibly serious health risks”.